Every winter the NHS publishes a run of emergency-care statistics that dominate headlines for a week and then recede. The Q4 2025/26 data — covering January to March 2026 — followed the usual rhythm: a cold January spike, a February plateau and an early-March easing. What the headlines rarely capture is how community pharmacy sits inside that curve.

This piece takes the Q4 NHS England A&E and Integrated Urgent Care (IUC) Aggregate Data Collection numbers in context and looks at where pharmacy fits. It does not try to explain the winter as a whole — it asks a narrower question: what role does community pharmacy play in absorbing or deflecting lower-acuity demand, and what does the most recent data suggest?

The Q4 picture in brief

The NHS England monthly A&E statistics show total major A&E attendances running at broadly the same level as the previous winter, with four-hour performance below the 95% standard for all three months of Q4. The IUC ADC data for the same period shows 111 call volumes elevated compared with the summer baseline but not materially higher than Q4 2024/25.

Three points from the data are relevant to community pharmacy:

1. Minor ailment attendances remain a meaningful share of A&E volume. Coding varies, but the proportion of Type 1 attendances discharged without follow-up or admission has stayed stable. A reasonable share of those could, in principle, have been managed in community pharmacy under Pharmacy First.
2. 111 dispositions to Pharmacy First continue to rise where local referral pathways are embedded, though the absolute share remains small compared with GP and self-care dispositions.
3. Walk-in Pharmacy First consultations are a larger volume than 111-referred consultations. The bulk of community pharmacy Pharmacy First activity is patient-initiated, not NHS-directed.

Why pharmacy sits in the lower-acuity corner

Pharmacy First, introduced in England in January 2024, formalised a role community pharmacy had long played informally: handling minor illnesses that do not need a GP but for which patients often present at A&E or urgent care in the absence of same-day primary-care capacity. The seven clinical pathways — sinusitis, sore throat, earache in children, infected insect bites, impetigo, shingles and uncomplicated UTI in women — are a deliberate match to the conditions most likely to end up in low-acuity A&E or urgent-care streams in winter.

PharmSee's live vacancy dataset at /app/jobs currently shows 1,742 active pharmacy roles across eleven major employers. The NHS Jobs share — 491 roles, roughly 28% of the total — reflects the growing pharmacist presence inside primary care and NHS trusts. Both the community and NHS sides of the workforce contribute to the urgent-care safety-net, but they do so differently: community pharmacy handles the unplanned walk-in; NHS primary care provides the structured same-day capacity that keeps the walk-ins low.

What the A&E performance data actually tells us about pharmacy

A common claim is that community pharmacy could "take pressure off A&E" by absorbing minor-ailment attendances. The data supports this only in a qualified way:

• The proportion of A&E attendances that are genuinely within the Pharmacy First clinical remit is small — single-digit percentages in most published audits.
• Even a substantial absolute increase in Pharmacy First consultation volumes would therefore only shave a modest fraction of winter A&E load.
• The larger effect of pharmacy on winter pressure is probably upstream: self-care advice, minor-ailment treatment, and vaccination that prevents the illness escalating in the first place.

This is not a criticism of the Pharmacy First programme — it is a realistic read of where the service fits. Winter pressure is primarily driven by respiratory admissions in the elderly, paediatric bronchiolitis and flu waves. These are not community pharmacy conditions. Where pharmacy helps most is by keeping the edge cases from piling onto already-full urgent-care streams.

Capacity constraints on the pharmacy side

The other half of the equation is whether community pharmacy has capacity to absorb more demand. The PharmSee employer-concentration index places Boots at 556 vacancies and Well at 331 vacancies — the two largest employers by advertised roles. Tesco, Cohens, Asda, Superdrug, Morrisons, Rowlands, Weldricks and Day Lewis make up most of the remainder. In aggregate, the vacancy count has sat around 1,600–1,750 for the last several months — a plateau that points to structural rather than cyclical demand.

A winter pressure surge on community pharmacy — whether via 111 referrals or walk-in volume — lands on a workforce that is already hiring hard. This matters because the Pharmacy First fee structure rewards completed consultations but relies on the consultation actually happening. A pharmacy short of a responsible pharmacist at 10 AM on a January Saturday cannot take a referral.

The IUC 111 dimension

The IUC ADC data includes a breakdown of 111 dispositions by outcome. Pharmacy is one option. Across 2025/26 the share of 111 contacts directed to a community pharmacy has grown modestly but remains below double digits in most regions. The pathway works best when:

• The local ICB has a defined referral flow into specific pharmacies.
• Those pharmacies have digital access to the 111 patient record.
• Pharmacy First workload is counted against capacity, not added on top of existing dispensing workload.

Where those conditions are not met, the referral pathway is fragile. A 111 handler who cannot find an accepting pharmacy within a reasonable distance will default to the GP out-of-hours or A&E stream, and the intended safety-net function is lost.

What community pharmacists can take from the data

Three practical observations for teams reading the Q4 numbers:

• Winter pressure on A&E is real but only modestly addressable through pharmacy. Avoid overclaiming the sector's role.
• Capacity discipline matters. If a pharmacy accepts Pharmacy First referrals, it needs to plan for them alongside the dispensing queue — not on top of it.
• Patient education on self-care and the Pharmacy First offer pays off earlier in the season. A family that knows their local pharmacy treats earache in under-17s will come to the counter in January rather than waiting in urgent care.

Where to find more

• Live pharmacy jobs and workforce data: /app/jobs
• Salary benchmarks across the network: /salary
• Pharmacy locator: /app/pharmacies

Caveats

This analysis is a qualitative read of publicly released NHS England A&E and IUC ADC data for Q4 2025/26. Direct attribution of A&E attendance changes to community pharmacy activity is difficult; the numbers cited above are directional indicators rather than causal estimates. Local ICB arrangements vary substantially and national averages may not reflect the picture in any given area.

Sources

• NHS England, A&E attendances and emergency admissions monthly statistics.
• NHS England, Integrated Urgent Care Aggregate Data Collection.
• NHS England, Pharmacy First service specification and evaluation updates.